VAUGHAN, Ontario, Feb. 20, 2019 /PRNewswire/ — CannTrust Holdings Inc. (“CannTrust” or the “Company”) (TSX:TRST) is pleased to announce that it has satisfied all the regulatory requirements to list its common shares on the New York Stock Exchange (“NYSE”).
Trading of the Company’s common shares on the NYSE will begin on Monday, February 25, 2019 under the ticker symbol “CTST”. The Company’s common shares will continue to be listed on the Toronto Stock Exchange under the ticker symbol “TRST”.
We are continuously looking to deliver shareholder value and the NYSE listing is a natural progression for CannTrust. We have taken steps to strengthen our management team to accelerate our growth as we face high demand for our products and expertise, both domestically and internationally.
Peter Aceto, Chief Executive Officer
Specifically, we have recently hired Greg Guyatt as Chief Financial Officer, who has demonstrated experience in international capital markets. We expect the NYSE listing will result in an expanded institutional and retail shareholder base, increased capital markets exposure and firmly establish CannTrust as a global company.
About CannTrust
CannTrust is a federally regulated licensed producer of medical and recreational cannabis in Canada, and the 2018 Canadian Cannabis Awards “Top Licensed Producer of the Year”. Founded by pharmacists, CannTrust brings more than 40 years of pharmaceutical and healthcare experience to the medical cannabis industry and serves more than 63,000 medical patients with its dried, extract and capsule products. The Company operates its 450,000 sq. ft. Niagara Perpetual Harvest Facility in Pelham, Ontario, and prepares and packages its product portfolio at its 60,000 sq. ft. manufacturing centre of excellence in Vaughan, Ontario.
CannTrust is developing nanotechnology to develop new products in the medical, recreational, beauty, wellness and pet markets. The Company has established its international footprint through a strategic partnership with Cannatrek Ltd. in Australia and a joint venture with STENOCARE in Denmark. The Company has also partnered with Breakthru Beverage Group through Kindred Canada, for recreational distribution in Canada. CannTrust is committed to research and innovation through partnerships with McMaster University in Ontario and Gold Coast University in Australia, which were designed to contribute to the growing body of evidence-based research regarding the use and efficacy of cannabis.
For more information, please visit www.canntrust.ca.
